Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Klaviyo (KVYO) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Klaviyo (KVYO) over the last 4 years, with Q4 2025 value amounting to $4.9 million.

  • Klaviyo's Gains from Investment Securities rose 1179.28% to $4.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 million, marking a year-over-year decrease of 2404.39%. This contributed to the annual value of $18.0 million for FY2025, which is 2404.39% down from last year.
  • Per Klaviyo's latest filing, its Gains from Investment Securities stood at $4.9 million for Q4 2025, which was up 1179.28% from $4.1 million recorded in Q3 2025.
  • Klaviyo's Gains from Investment Securities' 5-year high stood at $62.8 million during Q3 2023, with a 5-year trough of $5000.0 in Q1 2023.
  • Over the past 4 years, Klaviyo's median Gains from Investment Securities value was $4.4 million (recorded in 2024), while the average stood at $9.5 million.
  • Data for Klaviyo's Gains from Investment Securities shows a peak YoY increase of 23720000.0% (in 2024) and a maximum YoY decrease of 9125.61% (in 2024) over the last 5 years.
  • Klaviyo's Gains from Investment Securities (Quarter) stood at $232000.0 in 2022, then soared by 7987.07% to $18.8 million in 2023, then plummeted by 76.54% to $4.4 million in 2024, then grew by 11.79% to $4.9 million in 2025.
  • Its Gains from Investment Securities was $4.9 million in Q4 2025, compared to $4.1 million in Q3 2025 and $4.6 million in Q2 2025.